Loading…
Small Business Hardship Relief Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2013 · fourth_quarter · Pharmacy
Bills with similar content found using semantic analysis.
Sources: Congress.gov
H.R.2410/S.1244, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2014, FDA initiatives; Critical Path initiative; and Human nutrition issues and initiatives. S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues. S.1197/H.R.1960, National Defense Authorization Act for Fical Year FY2014, Defensewide RDT&E and Defense Health Program; and Medication Therapy Management.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Health Issues
Appropriations for Patient Protection and Affordable Care Act (ACA) Behavioral Health Information Technology Act (HR 2005) - (S 1517) State Flexibility Act (HR 1683) The BPCA and PREA Reauthorization Act (HR 4274)Preserving Access to Life Saving Medications Act (S 296) - (HR 2245) Drug Shortage Prevention Act (HR 3839) Food and Drug Administration Safety and Innovation Act (S 3187) - (HR 5651) Synthetic Drug Abuse Prevention Act (S 3190) - (HR 1254) Synthetics are Dangerous Act (HR 4205) Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2013 (S 3295) - (HR 3070) Mental Health Awareness and Improvement Act (S 689) HR 2757 to Ammend Title XIX of the Social Security Act Native American Psychiatric and Mental Health Care Improvement Act (HR 2037) Excellence in Mental Health Act (HR 1262)
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2013 · third_quarter · Pharmacy
H.R.2410/S.1244, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2014, FDA initiatives; Critical Path initiative; and Human nutrition issues and initiatives. S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues. S.1034/H.R.1960, National Defense Authorization Act for Fical Year FY2014, Defensewide RDT&E and Defense Health Program; and Medication Therapy Management.
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
2013 · second_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Pharmacy
H.R.2410/S.1244, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2014, FDA initiatives; Critical Path initiative; and Human nutrition issues and initiatives. S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues. S.1034/H.R.1960, National Defense Authorization Act for Fical Year FY2014, Defensewide RDT&E and Defense Health Program; and Medication Therapy Management.
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
2013 · second_quarter · Health Issues
Pandemic preparedness, Tamiflu, Medicare coverage of Cancer Drugs, Appropriations.; S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 1416, Cancer Patient Protection Act of 2013; S. 957, Drug Supply Chain Security Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; compounding issues; FY 13 Labor HHS Appropriations legislation; issues related to FDA user fee reauthorization; H.R. 942 S. 1577; S. 3187; Pedigree and biologics issues; H.R. 905: ASP issues; H.R. 5651; issues concerning drug compounding. Implementation of Patient Protection and Affordable Care Act; Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. Legislation on screening, care and treatment for hepatitis; implementation of section 340B of the Public Health Service Act (42 U.S.C. 256b); Implementation of H.R. 1: Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA stimulus. Avastin-use in breast cancer treatment: general patient reform isse: implementation of the Affordable Care Act of 2010; Issues relating to the treatment of biologics in international health programs.
Client expense: $1,077,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Health Issues
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Taxation/Internal Revenue Code
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Pharmacy
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2014, FDA initiatives; and Critical Path initiative. S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues. National Defense Authorization Act for Fical Year FY2014, Defensewide RDT&E.
Client expense: Not reported · Firm income: $30,000
Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE
2013 · first_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Taxation/Internal Revenue Code
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Health Issues
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Health Issues
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Taxation/Internal Revenue Code
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act. Monitor tax reform. Dextromethorphan, Pseudoephedrine restriction issues.
Client expense: Not reported · Firm income: Not reported
2013 · first_quarter · Pharmacy
OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187. Fairness to Pet Owners Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE